Institut für Versorgungsforschung in der Onkologie

Recent papers from Institut für Versorgungsforschung in der Onkologie

1. Canakinumab or emavusertib for anemia in lower-risk MDS: results of the CANFIRE and LUCAS phase 2, open-label, multicenter trialsCommunications Medicine · 2026
2. Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera – German real-world data (PaVe study)Annals of Hematology · 2026
3. Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo TrialJournal of Clinical Oncology · 2026
4. Real-world progression-free survival and overall survival in patients with HR⁺/HER2⁻ advanced breast cancer treated in first-line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study.2026
5. Abstract PS5-04-27: Quality of life in patients with advanced breast cancer (aBC) treated with ribociclib (RIB) in the real-world RIBANNA trialClinical Cancer Research · 2026
6. Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA studyESMO Open · 2025
7. Is the association between visit- to- visit heart rate variability and cardiovascular disease mediated by arteriopathy as measured by carotid intima- media thickness?Journal of Stroke and Cerebrovascular Diseases · 2025
8. Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCThe Breast · 2025
9. Abstract PS14-07: Exploring Circulating Leukocyte RNA Expression: Implications for Treatment Outcomes and Immune-Related Adverse Events in Patients with Triple Negative Breast Cancer Enrolled in the GeparNuevo TrialCancer Research · 2024
10. Metastatic Breast Cancer: Prolonging Life in Routine Oncology CareCancers · 2024
11. Treatment challenges of ruptured intracranial aneurysms during pregnancy: A case record and review of the literatureBrain and Spine · 2024
12. Critical Assessment of Methods of Protein Structure Prediction (CASP) – Round XV2023
13. Patients with indolent lymphomas are at high risk of infections: experience from a German outpatient clinicBMC Immunology · 2023
14. Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer RegistryESMO Open · 2022
15. Patients with indolent lymphomas are at high risk of infections - Experience from a German outpatient clinic2022
16. Shared decision‐making in routine breast cancer care in Germany—A cross‐sectional studyPsycho-Oncology · 2022
17. Contrast-enhanced ultrasound with perfusion analysis in patients with venous malformations before and after percutaneous treatment with ethanol-gelClinical Hemorheology and Microcirculation · 2020
18. Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacementBMC Immunology · 2020
19. Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995–2017Leukemia & lymphoma/Leukemia and lymphoma · 2019
20. Privigen® has similar pharmacokinetic properties in primary and secondary immune deficiencyInternational Immunopharmacology · 2018